These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Tang M; Ryman DC; McDade E; Jasielec MS; Buckles VD; Cairns NJ; Fagan AM; Goate A; Marcus DS; Xiong C; Allegri RF; Chhatwal JP; Danek A; Farlow MR; Fox NC; Ghetti B; Graff-Radford NR; Laske C; Martins RN; Masters CL; Mayeux RP; Ringman JM; Rossor MN; Salloway SP; Schofield PR; Morris JC; Bateman RJ; Lancet Neurol; 2016 Dec; 15(13):1317-1325. PubMed ID: 27777020 [TBL] [Abstract][Full Text] [Related]
14. Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force. Aisen PS; Bateman RJ; Carrillo M; Doody R; Johnson K; Sims JR; Sperling R; Vellas B J Prev Alzheimers Dis; 2021; 8(3):306-312. PubMed ID: 34101788 [TBL] [Abstract][Full Text] [Related]
15. Can Anti-β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease? Imbimbo BP; Lucca U; Watling M Neurol Genet; 2021 Feb; 7(1):e535. PubMed ID: 33575481 [TBL] [Abstract][Full Text] [Related]
16. [Significance and progress of DIAN/A4/API]. Shimada H Nihon Rinsho; 2016 Mar; 74(3):417-22. PubMed ID: 27025079 [TBL] [Abstract][Full Text] [Related]